Chemical modulators of pro-apoptotic BAX and BCL-2 polypeptides

Details for Australian Patent Application No. 2009302840 (hide)

Owner Dana Farber Cancer Institute

Inventors Walensky, Loren D.; Gavathiotis, Evripidis

Agent Pizzeys

Pub. Number AU-A-2009302840

PCT Pub. Number WO2010/042225

Priority 61/136,906 10.10.08 US

Filing date 9 October 2009

Wipo publication date 15 April 2010

International Classifications

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

Event Publications

10 March 2011 PCT application entered the National Phase

  PCT publication WO2010/042225 Priority application(s): WO2010/042225

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009302845-A method for a payment cardholder to control and manage the use of a payment card

2009302838-Optimizing refinery hydrogen gas supply, distribution and consumption in real time